ArticleJournal of hepatology2020
Reply to: "Clinical characteristics of COVID-19 patients with abnormal liver tests".
Article in Journal of hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.
- AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19.Gastroenterology · 2020Pooled it
- Hepatology Consultants Often Disagree on Etiology of Abnormal Liver Biochemistries in COVID-19 but Agree on Management.Digestive diseases and sciences · 2021Article
- Characteristics of Liver Function in Patients With SARS-CoV-2 and Chronic HBV Coinfection.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2021Article
- Systemic inflammation as fuel for acute liver injury in COVID-19.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2021Article
- COVID-19 Pandemic: Advances in Diagnosis, Treatment, Organoid Applications and Impacts on Cancer Patient Management.Frontiers in medicine · 2021Review
- Smoking and Liver Disease.Gastroenterology & hepatology · 2020Article
- High aspartate aminotransferase to alanine aminotransferase ratio on admission as risk factor for poor prognosis in COVID-19 patients.Scientific reports · 2020Article
- Author response to Letter to the Editor: Potential implications of COVID-19 in non-alcoholic fatty liver disease.Liver international : official journal of the International Association for the Study of the Liver · 2020Article
- Development and Validation of the Quick COVID-19 Severity Index: A Prognostic Tool for Early Clinical Decompensation.Annals of emergency medicine · 2020Observational
- Liver injury in COVID-19: Diagnosis and associated factors.Liver international : official journal of the International Association for the Study of the Liver · 2020Article
- Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: Should we worry?Liver international : official journal of the International Association for the Study of the Liver · 2020Article
- Coronavirus Disease 2019: A Gastroenterologist's Perspective in May 2020.Gastroenterology research · 2020Review
- Interrelationship Between Coronavirus Infection and Liver Disease.Clinical liver disease · 2020Review
Corrections and comments
- Comment on
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.